APA (7th ed.) Citation

M, F., C, S., A, S., M, L., E, B., NN, G., . . . CL, G. (2023). Real-world HbA1c changes and prescription characteristics among type 2 diabetes mellitus patients initiating treatment with once weekly semaglutide for diabetes. Journal of diabetes and metabolic disorders, 23(1), 727. https://doi.org/10.1007/s40200-023-01341-y

Chicago Style (17th ed.) Citation

M, Frazer, et al. "Real-world HbA1c Changes and Prescription Characteristics Among Type 2 Diabetes Mellitus Patients Initiating Treatment with Once Weekly Semaglutide for Diabetes." Journal of Diabetes and Metabolic Disorders 23, no. 1 (2023): 727. https://doi.org/10.1007/s40200-023-01341-y.

MLA (9th ed.) Citation

M, Frazer, et al. "Real-world HbA1c Changes and Prescription Characteristics Among Type 2 Diabetes Mellitus Patients Initiating Treatment with Once Weekly Semaglutide for Diabetes." Journal of Diabetes and Metabolic Disorders, vol. 23, no. 1, 2023, p. 727, https://doi.org/10.1007/s40200-023-01341-y.